Scarica l'app Stockscreener
6.99
0.99%
-0.07
Pre-mercato:
6.93
-0.06
-0.86%
Kamada Ltd Borsa (KMDA) Ultime notizie
Kamada Ltd (KMDA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Kamada Ltd (KMDA) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Kamada Ltd (KMDA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Kamada Ltd (KMDA) Cash Flow - TradingKey
Kamada Ltd. Revenue Breakdown – NASDAQ:KMDA - TradingView
Kamada Ltd. (KMDA) Stock Analysis: Exploring an 86.78% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
Kamada Ltd (KMDA) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Kamada Ltd. (KMDA) Sees Slight Decline as Shares Test Key Support ZoneCall Dominated - dars.gov.et
Kamada stock trades steadily as plasma-derived therapies support revenue growth - Ad-hoc-news.de
Kamada stock holds at Buy as Benchmark cites $50M plasma deal - Investing.com UK
Kamada secures $50M plasma supply deal over three years By Investing.com - Investing.com Nigeria
Kamada Signs $50 Million Plasma Supply Agreement With Biopharmaceutical Firm - Moomoo
Kamada jumps on $50m source plasma dealGlobes - Globes - Israel Business News
Kamada (KMDA) Secures $50M Plasma Supply Agreement - GuruFocus
Kamada Signs Three-Year, $50 Million Plasma Supply Deal to Bolster Growth - TipRanks
Kamada secures $50M plasma supply deal over three years - Investing.com
Kamada Announces a Three-Year $50 Million Sales Agreement to Supply Plasma to a Leading Biopharmaceutical Company focused on Plasma-derived Therapies - The Manila Times
Kamada Ltd. (NASDAQ: KMDA) signs three-year $50M plasma supply agreement - Stock Titan
Kamada’s centers plan ~50,000 liters of plasma each at full capacity - Stock Titan
Kamada signs three-year USD 50 million plasma supply agreement with biopharmaceutical company - Bitget
Uri Botzer Net Worth (2026) - GuruFocus
Kamada Showcases New CYTOGAM Data from 2026 ISHLT Meeting, Signaling Potential Uptick in Transplant Use - TipRanks
Kamada highlights study results on CYTOGAM in transplants - Investing.com UK
symbol__ Stock Quote Price and Forecast - CNN
Kamada highlights Cytogam study results - TipRanks
Kamada highlights study results on CYTOGAM in transplants By Investing.com - Investing.com South Africa
Kamada (KMDA) Presents Promising Cytogam Study Results at Global Conference - GuruFocus
[6-K] KAMADA LTD Current Report (Foreign Issuer) | KMDA SEC FilingForm 6-K - Stock Titan
Kamada Highlights CYTOGAM® Study Results Presented at the 2026 ISHLT Annual Meeting - GlobeNewswire
How (KMDA) Movements Inform Risk Allocation Models - Stock Traders Daily
Enterprise value to EBITDA forward of Kamada Ltd. – NASDAQ:KMDA - TradingView
Price to earnings forward of Kamada Ltd. – NASDAQ:KMDA - TradingView
Price to earnings forward of Kamada Ltd – TASE:KMDA - TradingView
Enterprise value to EBIT forward of Kamada Ltd. – NASDAQ:KMDA - TradingView
Kamada Ltd outlines plasma-derived therapies strategy. Investor focus on specialty biologics pipelin - Ad-hoc-news.de
Kamada Ltd. Q1 2026 Earnings: EPS Misses Estimates, Stock Declines SlightlyPost-Earnings Reaction - dars.gov.et
Kamada Ltd. (KMDA) Holds Steady Near Support as Technical Indicators Suggest ConsolidationPairs Trade - dars.gov.et
Kamada Ltd. (KMDA) Holds Steady as Shares Trade Near Midpoint of RangeMax Pain Level - dars.gov.et
Trading Systems Reacting to (KMDA) Volatility - Stock Traders Daily
KMDAKamada Ltd Latest SEC Filings - Finviz
Kamada Ltd updates drug portfolio as Nasdaq-listed biopharma pursues growth - ad-hoc-news.de
Kamada (KMDA) Corporate Presentation Summary - Quartr
Daichi Kamada Contract Boost Gives Crystal Palace Sage Win - Read Crystal Palace
KMDA Q1 2026 Earnings: EPS Misses Estimates, Stock Gains SlightlyFull Year Guidance - dars.gov.et
Kamada Ltd Actuals & Estimates (NASDAQ:KMDA) - TradingView
Kamada eyed by Milan and Fiorentina as Crystal Palace midfielder linked with Serie A return - Football Italia
KMDA Forecast — Price Target — Prediction for 2027 - TradingView
Kamada Ltd. (KMDA) Posts Modest Gain as Shares Hold Above Key Support LevelOverbought Signal Alerts - dars.gov.et
KMDA Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Kamada Ltd (KMDA) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Daichi Kamada World Cup form gives Crystal Palace fresh momentum - Read Crystal Palace
Japan coach Moriyasu praises Kamada after standout performance in new role - CNA
FIFA World Cup 2026: Japan rout Tunisia in World Cup's 1,000th match - Rediff
Japan takes step toward knockout stage with 4-0 rout of Tunisia - The Japan Times
Tunisia Vs Japan, FIFA World Cup 2026 In Pics: See Best Photos From Estadio Monterrey - Outlook India
Kamada strikes early to take Japan 1-0 lead against Tunisia - Views Bangladesh
Japan turn to Kamada, Ito with Kubo sidelined for Tunisia clash - CNA
How Kamada Ltd. (KMDA) Affects Rotational Strategy Timing - Stock Traders Daily
Kamada Stockweekly review against biotech peers - AD HOC NEWS
Kamada schedules annual shareholder meeting for August in Rehovot By Investing.com - Investing.com Canada
Kamada schedules annual shareholder meeting for August in Rehovot - Investing.com
Kamada (NASDAQ: KMDA) plans 2026 AGM on directors, option grants and ISO pool - Stock Titan
Kamada Ltd (KMDA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Kamada Ltd (KMDA) Valuation: PE, PB & Fair Value Analysis - TradingKey
0.30%
2.01%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):